The EU Commission announced on 8 October that one of this year’s Nobel Prize laureates, Sir Peter J. Ratcliffe, had received EU funding for his research projects.

Along with William G. Kaelin Jr and Gregg L. Semenza, Ratcliffe has been awarded the Nobel Prize in Physiology or Medicine for 2019 for his discoveries of how cells adapt to changes in oxygen levels, which is key to fighting a large number of diseases, including anaemia and cancer.

Representing the University of Oxford, Ratcliffe participated in the EU-funded EUROXY project, which received €8 million from the EU’s Sixth Framework Programme for science and research, and focused on identifying adaptive pathways of cancer cells as a way to eradicate cancer.

In 2008, he was awarded an Advanced Grant of €3 million from the European Research Council, together with Christopher J. Schofield, for a project that provided a structural characterisation of human hydroxylase enzymes and could in the future be of therapeutic use in ischaemic disease and cancer.